AzTrials
AzTrials

Dental Implant, Single-ToothNCT01871220

Periimplant Mucosa Dynamics Around Divergent and Concave Atlantis Abutment Transition Profiles

A study testing Concave Transition Profile and Divergent Transition Profile in people with Dental Implant, Single-Tooth and Esthetics, Dental, run by Christopher Barwacz at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the effect of two different implant abutment designs on gum tissue volume changes over time after implant placement. Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
What is being tested?
Concave Transition Profile and Divergent Transition Profile
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
61 participants
Where
1 siteUnited States
Study dates
30 Dec 2013to 3 Oct 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years of age or greater
  • Subjects requiring replacement of a single-rooted tooth in the maxillary arch from first premolar to first premolar with an implant-supported restoration
  • Teeth adjacent (mesial and distal) to study site must consist of two stable, natural teeth without signs of periodontal bone loss (<2.0mm) and/or significant soft tissue loss
  • An opposing dentition with teeth, implants, or fixed prosthesis
  • Subjects must be willing to follow instructions related to the study procedures
  • Subjects must have read, understood, and signed the informed consent document

Who cannot join

  • Insufficient interocclusal space for implant placement and/or restoration at study site
  • More than 2.0mm vertical bone loss at study site as measured from the mid-buccal crest of the bone on the adjacent teeth
  • Untreated rampant caries
  • Tobacco use free for ≤ 6 months
  • Liver or kidney disfunction/failure
  • Active severe infectious diseases that may affect normal healing and/or bone metabolism (e.g. AIDS)
Show all 15Show fewer
  • Uncontrolled diabetes
  • Current alcohol or drug abuse
  • Need for systemic corticosteroids or any other medication that would influence post-operative healing and/or osseointegration
  • History of relevant head/neck cancer and/or radiation of the head/neck
  • Subjects who currently use bisphosphonates or have a history of bisphosphonate use
  • Subjects with metabolic bone diseases such as osteoporosis or Paget's disease of bone
  • Known pregnancy or nursing mothers
  • Unable or unwilling to return for follow-up visits for a period of 1 year
  • Unlikely to be able to comply with study procedures according to investigators judgement

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Iowa College of Dentistry

    Iowa City, Iowa, 52242

Other trials in United States

About this study

Official title: Peri-implant Mucosa Dynamics Around Divergent and Concave Atlantis™ Abutment Transition Profiles.

The purpose of this study is to compare the effect of two different implant abutment designs on gum tissue volume changes over time after implant placement.

Read the detailed description

This is a randomized, prospective, controlled clinical trial comparing the facial gingival profiles around Atlantis™ abutments that have either a linear "divergent" or "concave" transitional profile on the facial and proximal aspect of the abutments.

Sixty study subjects requiring replacement of a single-rooted tooth with an implant-supported restoration will be recruited.

The Osseospeed™ Plus implant will be placed for all 60 subjects, with the use of Uni healing abutments to minimize lateral tissue displacement during healing. After implant placement, but before final impressions are obtained (8 weeks post-placement), subjects will be randomized to either a "divergent" or a "concave" transmucosal abutment design. For fabrication of the experimental abutment, Atlantis™ engineers will initially design a control "divergent" prototype that will be modified with a concavity on the facial and proximal transition zones to obtain an abutment that will otherwise retain all the features of the control abutment. Engineers will measure the linear topographical changes (ΔL=Lc-Ld) of the transition zone, as well as the volumetric change (x) on the mid-facial aspect of the abutment induced by the formation of a submucosal concavity. The primary outcome of the study will be the apico-coronal change of the peri-implant mucosal zenith from prosthesis delivery to one year.

Being tested
Concave Transition Profile, Divergent Transition Profile
Keywords
Implant Abutments, Oral Mucosa Changes, Implant Esthetics

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Concave Transition ProfileDevice

    An Atlantis abutment is delivered with a concave transition profile.

  • Divergent Transition ProfileDevice

    An Atlantis abutment is delivered with a linear transition profile

Study groups in NCT01871220
Study groupRoleWhat they receive
Divergent AbutmentActive comparatorDivergent Transition Profile
Receives: Device: Divergent Transition Profile
Concave AbutmentExperimentalConcave Transition Profile
Receives: Device: Concave Transition Profile

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peri-Implant Mucosal Zenith Distance (in Millimeters) at the Concave/Divergent Abutment Sites

    Determine if there is a difference in soft tissue peri-implant zenith changes (in millimeters) for the concave/divergent abutment sites, specifically between at delivery and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery. This measurement is taken using a standardized stereotactic digital photography system that allows for increased measurement accuracy and precision, specifically with the Canfield Dental Camera, Canfield Imaging Systems.

    Measured: Delivery, and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery

Secondary outcomes (2)
  1. Submarginal Buccal-lingual Thickness (Millimeters) in the Peri-implant Transition Zone Relative to a Fixed Reference Point After Prosthesis Delivery

    Determine if there is a difference in submarginal buccal-lingual soft tissue thickness in the peri-implant transition zone relative to a fixed reference point, specifically at baseline and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery. This measurement is taken using a standardized stereotactic digital photography system that allows for increased measurement accuracy and precision, specifically with the Canfield Dental Camera, Canfield Imaging Systems.

    Measured: Baseline and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery

  2. Keratinized Mucosa Width (Millimeters) at the Midfacial Aspect of the Implant Site.

    Determine if there is a difference in Keratinized Mucosa Width (millimeters) in the apico-coronal direction at the midfacial aspect of the implant site, specifically at baseline and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery. This measurement is taken using a standardized stereotactic digital photography system that allows for increased measurement accuracy and precision, specifically with the Canfield Dental Camera, Canfield Imaging Systems.

    Measured: Baseline and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2013 (estimated)
  2. Study start30 Dec 2013
  3. Primary completion3 Oct 2018
  4. Study completion3 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
61 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01871220
Sponsor's protocol ID
201302798
Status last verified
May 2022
First submitted
3 Jun 2013
Last updated
14 Jun 2022
Data monitoring committee
No
Individual data sharing
No

Publications

  • Barwacz CA, Swenson M, Couso-Queiruga E, Comnick C, Xie XJ, Avila-Ortiz G. Effect of CAD/CAM Abutment Morphology on the Outcomes of Implant Therapy: A Randomized Controlled Trial. Clin Oral Implants Res. 2025 Mar;36(3):374-385. doi: 10.1111/clr.14389. Epub 2024 Dec 6.

    PubMed 39641983

Questions about this trial

What is this clinical trial studying?

A study testing Concave Transition Profile and Divergent Transition Profile in people with Dental Implant, Single-Tooth and Esthetics, Dental, run by Christopher Barwacz at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 14 Jun 2022). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peri-Implant Mucosal Zenith Distance (in Millimeters) at the Concave/Divergent Abutment Sites (time frame: Delivery, and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01871220, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in